Click on headlines below to download research

Value-added strategy drives H118 uplift
Tonkens Agrar | 23/04/2018

Management’s strategy of generating more profit from its crops by selling processed onions and potatoes, supported by higher farm gate milk prices…

Higher marketing spend key to growth
Cliq Digital | 23/04/2018

CLIQ Digital’s FY17 results were slightly short of guidance and consensus estimates, yet still delivered 23% increase in net income underpinned by…

Expansion of fintech portfolio continues
FinLab | 18/04/2018

FinLab continues to expand its portfolio of fintech investments (currently nine holdings), putting special emphasis on opportunities in the blockchain…

Strong gains allow further diversification
Heliad Equity Partners | 11/04/2018

Heliad Equity Partners (Heliad) posted strong results for FY17, with profit before tax of €39.6m compared with a loss of €22.2m in FY16. This…

Bumps in the road
Borussia Dortmund | 10/04/2018

While longstanding brand and financial strengths hold true, Borussia Dortmund (BVB) is currently bedevilled by uncertainties. Some, such as the absence…

New world of integrated smart surfaces
Nanogate | 05/04/2018

Nanogate is taking innovative surfaces to the next level, offering intelligent surfaces with embedded electronic circuits where the surface itself interacts…

Yakult joined the pivotal RESMAIN study
4SC | 28/03/2018

Together with its Q417 results announced last week, 4SC also reported progress with its R&D activities. All three lead assets – resminostat,…

Solid 2017 results but still low rating
Nürnberger Beteiligungs | 27/03/2018

The turnaround in business levels in life insurance after the weak first half improves visibility, although the overall environment remains challenging.…

Increased focus on securing high margins
Helma Eigenheimbau | 27/03/2018

Helma’s FY17 results exhibit moderate growth (sales up 1.4% y-o-y) due to constrained capacity in the German construction market. However, demand…

TCR enters the clinic
Medigene | 27/03/2018

Medigene has started its TCR Phase I/II clinical trial, making it one of the few clinical TCR companies globally. Combined with the completed enrolment…

Muted Q417 does not spoil FY18 outlook
JDC Group | 23/03/2018

JDC Group has been successful in implementing its fintech strategy so far and continues to acquire new insurance portfolios, as illustrated by the recent…

EverSweet
Evolva | 22/03/2018

The announcement that Cargill has officially started producing EverSweet brings commercial reality to Evolva’s stevia product, after years of R&D.…

VAR business reaches inflection point
Mensch & Maschine Software | 14/03/2018

Mensch und Maschine’s FY17 results confirmed that its Software business continues to generate strong growth and margins. The VAR business managed…

Contract wins provide excellent references
artec technologies | 09/03/2018

artec has won three prestigious new contracts in recent months that provide a strong endorsement of the company’s new platform. The wins come in…

Slower AUM growth and delayed disposals
publity | 06/03/2018

The recent selling pressure on publity’s shares (price down 48% ytd) was accompanied by negative newsflow in January, including a profit warning…

Finding its feet
Borussia Dortmund | 06/03/2018

While arguably riding its luck of late, Borussia Dortmund (BVB) is well-placed to exploit immediate Bundesliga and Europa League opportunities. However,…

Investing in business development
MPC Capital | 26/02/2018

MPC Capital met its 2017 financial performance targets. The share price has suffered in the recent shake-out. P/NAV has slipped to a relatively undemanding…

Acquisitions significantly broaden the offering
DATAGROUP | 26/02/2018

FY17 was a year of strong growth for DATAGROUP, with revenues rising by 28% and EBITDA surging 42%. The EBITDA margin rose by 120bp to a record 12.1%.…

US NanoTherm IDE approval a major milestone
MagForce | 23/02/2018

MagForce has received IDE approval to start its first pivotal clinical trial evaluating NanoTherm focal ablation therapy for prostate cancer in the US.…

Preliminary FY17 sales in line with guidance
aap Implantate | 21/02/2018

aap Implantate’s preliminary FY17 results show an encouraging 20% y-o-y growth in trauma revenues, with the strongest performance coming from the…

Positive developments for private/public fund
HBM Healthcare Investments | 14/02/2018

HBM Healthcare Investments (HBMN) reported profits of CHF72m for the third quarter of its financial year, buoyed by the takeover of long-term holding Advanced…

Steady progress in the first quarter of FY18
Deutsche Beteiligungs | 13/02/2018

Deutsche Beteiligungs (DBAG) reported a 2.7% NAV return for the three months ended 31 December 2017, with the period characterised by a high level of transaction…

Booking record growth
Edel | 12/02/2018

Edel’s results to September 2017 were comfortably ahead of earlier guidance, revised post year-end. Revenues were boosted by good demand at Optimal…

Steady R&D newsflow
4SC | 09/02/2018

Over the past several months 4SC has reported progress with both its clinical-stage assets – resminostat and 4SC-202. The pivotal trial with resminostat…

A record year; proposed dividend
Beta Systems | 31/01/2018

Beta’s FY17 results were towards to the middle of its guidance; strong licence sales in DCI and management’s efficiency drive resulted in a…